Sign In    Register

World Journal of Emergency Medicine ›› 2018, Vol. 9 ›› Issue (1): 64-66.doi: 10.5847/wjem.j.1920-8642.2018.01.010

• Brief Report • Previous Articles     Next Articles

First-in-man implantation of the retrievable and repositionable VenusA-Plus valve

Xian-bao Liu1, Yu-xin He1, Chun-hui Liu1, Li-han Wang1, Feng Gao1, Lei Yu1, Ai-qiang Dong2, Min-jian Kong2, Ji-fang Chen1, Yong Xu3, Qi-jing Zhou4, Min Yan3, Jian-an Wang1()   

  1. 1Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
    2Department of Cardiovascular Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
    3Department of Anesthesiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
    4Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • Received:2017-11-28 Accepted:2017-12-10 Online:2018-03-15 Published:2018-03-15
  • Contact: Jian-an Wang E-mail:wangjianan111@zju.edu.cn

RichHTML

4

PDF (PC)

595

Abstract:

BACKGROUND: No retrievable and repositionable second generation transcatheter aortic valve is available in China. Here, we report the first-in-man implantation of the retrievable and repositionable VenusA-Plus valve.
METHODS: A 76-year-old patient with symptomatic severe aortic stenosis and high surgical risk (STS 13.8%) was recommended for transcatheter aortic valve replacement (TAVR) by heart valve team. Type 0 bicuspid aortic valve with asymmetric calcification was identified by dual source computed tomography, and the unfavorable anatomies increased the possibility of malposition and paravalvular leakage during TAVR. Therefore, we used the retrievable and repositionable VenusA-Plus valve for the patient.
RESULTS: Transfemoral TAVR was performed under local anesthesia with sedation, and a 26-mm VenusA-Plus valve was successfully implanted. No transvalvular pressure gradient and trace paravalvular leakage were found.
CONCLUSION: The successful first-in-man implantation indicates the retrievable and repositionable VenusA-Plus valve is feasible in complicated TAVR cases such as bicuspid aortic valve.

Key words: Transcatheter aortic valve replacement, VenusA-Plus valve, Retrievable, Repositionable, Bicuspid aortic valve